世界の高親和性神経成長因子受容体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global High Affinity Nerve Growth Factor Receptor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5780 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、高親和性神経成長因子受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ASP-7962、AZD-7451、BNN-27、Cenegermin、CRB-0089、その他）、用途別市場規模（胆管がん、乳頭状甲状腺がん、腰痛、肺がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・高親和性神経成長因子受容体の市場動向 ・企業の競争状況、市場シェア ・高親和性神経成長因子受容体の種類別市場規模と予測2016-2027（ASP-7962、AZD-7451、BNN-27、Cenegermin、CRB-0089、その他） ・高親和性神経成長因子受容体の用途別市場規模と予測2016-2027（胆管がん、乳頭状甲状腺がん、腰痛、肺がん、その他） ・高親和性神経成長因子受容体の北米市場規模2016-2027（アメリカ、カナダ） ・高親和性神経成長因子受容体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・高親和性神経成長因子受容体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・高親和性神経成長因子受容体の中南米市場規模2016-2027（メキシコ、ブラジル） ・高親和性神経成長因子受容体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Array BioPharma Inc、Astellas Pharma Inc、AstraZeneca Plc、Daiichi Sankyo Co Ltd、Dompe Farmaceutici SpA、Genzyme Corp、Handok Inc、Ignyta Inc、Loxo Oncology Inc、Merck & Co Inc、Nerviano Medical Sciences Srl、Plexxikon Inc、Proximagen Ltd、Rottapharm Biotech Srl、Sienna Biopharmaceuticals Inc、Tiziana Life Sciences Plc） ・結論

Market Analysis and Insights: Global High Affinity Nerve Growth Factor Receptor Market
The global High Affinity Nerve Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global High Affinity Nerve Growth Factor Receptor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global High Affinity Nerve Growth Factor Receptor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global High Affinity Nerve Growth Factor Receptor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global High Affinity Nerve Growth Factor Receptor market.

Global High Affinity Nerve Growth Factor Receptor Scope and Market Size
High Affinity Nerve Growth Factor Receptor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global High Affinity Nerve Growth Factor Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others

Segment by Application
Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 ASP-7962
1.2.3 AZD-7451
1.2.4 BNN-27
1.2.5 Cenegermin
1.2.6 CRB-0089
1.2.7 Others
1.3 Market by Application
1.3.1 Global High Affinity Nerve Growth Factor Receptor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Bile Duct Cancer
1.3.3 Papillary Thyroid Cancer
1.3.4 Low Back Pain
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global High Affinity Nerve Growth Factor Receptor Market Perspective (2016-2027)
2.2 High Affinity Nerve Growth Factor Receptor Growth Trends by Regions
2.2.1 High Affinity Nerve Growth Factor Receptor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 High Affinity Nerve Growth Factor Receptor Historic Market Share by Regions (2016-2021)
2.2.3 High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Regions (2022-2027)
2.3 High Affinity Nerve Growth Factor Receptor Industry Dynamic
2.3.1 High Affinity Nerve Growth Factor Receptor Market Trends
2.3.2 High Affinity Nerve Growth Factor Receptor Market Drivers
2.3.3 High Affinity Nerve Growth Factor Receptor Market Challenges
2.3.4 High Affinity Nerve Growth Factor Receptor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue
3.1.1 Global Top High Affinity Nerve Growth Factor Receptor Players by Revenue (2016-2021)
3.1.2 Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Players (2016-2021)
3.2 Global High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by High Affinity Nerve Growth Factor Receptor Revenue
3.4 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio
3.4.1 Global High Affinity Nerve Growth Factor Receptor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High Affinity Nerve Growth Factor Receptor Revenue in 2020
3.5 High Affinity Nerve Growth Factor Receptor Key Players Head office and Area Served
3.6 Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
3.7 Date of Enter into High Affinity Nerve Growth Factor Receptor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 High Affinity Nerve Growth Factor Receptor Breakdown Data by Type
4.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Type (2016-2021)
4.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2022-2027)

5 High Affinity Nerve Growth Factor Receptor Breakdown Data by Application
5.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Application (2016-2021)
5.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America High Affinity Nerve Growth Factor Receptor Market Size (2016-2027)
6.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Type
6.2.1 North America High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021)
6.2.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027)
6.2.3 North America High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2027)
6.3 North America High Affinity Nerve Growth Factor Receptor Market Size by Application
6.3.1 North America High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021)
6.3.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027)
6.3.3 North America High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2027)
6.4 North America High Affinity Nerve Growth Factor Receptor Market Size by Country
6.4.1 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021)
6.4.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe High Affinity Nerve Growth Factor Receptor Market Size (2016-2027)
7.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Type
7.2.1 Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021)
7.2.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027)
7.2.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2027)
7.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Application
7.3.1 Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021)
7.3.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027)
7.3.3 Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2027)
7.4 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country
7.4.1 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021)
7.4.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size (2016-2027)
8.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Type
8.2.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2027)
8.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Application
8.3.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2027)
8.4 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region
8.4.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size (2016-2027)
9.2 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Type
9.2.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021)
9.2.2 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027)
9.2.3 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2027)
9.3 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Application
9.3.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021)
9.3.2 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027)
9.3.3 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2027)
9.4 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country
9.4.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021)
9.4.2 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size (2016-2027)
10.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type
10.2.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2027)
10.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application
10.3.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2027)
10.4 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country
10.4.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Array BioPharma Inc
11.1.1 Array BioPharma Inc Company Details
11.1.2 Array BioPharma Inc Business Overview
11.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Introduction
11.1.4 Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.1.5 Array BioPharma Inc Recent Development
11.2 Astellas Pharma Inc
11.2.1 Astellas Pharma Inc Company Details
11.2.2 Astellas Pharma Inc Business Overview
11.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Introduction
11.2.4 Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.2.5 Astellas Pharma Inc Recent Development
11.3 AstraZeneca Plc
11.3.1 AstraZeneca Plc Company Details
11.3.2 AstraZeneca Plc Business Overview
11.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Introduction
11.3.4 AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.3.5 AstraZeneca Plc Recent Development
11.4 Daiichi Sankyo Co Ltd
11.4.1 Daiichi Sankyo Co Ltd Company Details
11.4.2 Daiichi Sankyo Co Ltd Business Overview
11.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Introduction
11.4.4 Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.4.5 Daiichi Sankyo Co Ltd Recent Development
11.5 Dompe Farmaceutici SpA
11.5.1 Dompe Farmaceutici SpA Company Details
11.5.2 Dompe Farmaceutici SpA Business Overview
11.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Introduction
11.5.4 Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.5.5 Dompe Farmaceutici SpA Recent Development
11.6 Genzyme Corp
11.6.1 Genzyme Corp Company Details
11.6.2 Genzyme Corp Business Overview
11.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Introduction
11.6.4 Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.6.5 Genzyme Corp Recent Development
11.7 Handok Inc
11.7.1 Handok Inc Company Details
11.7.2 Handok Inc Business Overview
11.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Introduction
11.7.4 Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.7.5 Handok Inc Recent Development
11.8 Ignyta Inc
11.8.1 Ignyta Inc Company Details
11.8.2 Ignyta Inc Business Overview
11.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Introduction
11.8.4 Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.8.5 Ignyta Inc Recent Development
11.9 Loxo Oncology Inc
11.9.1 Loxo Oncology Inc Company Details
11.9.2 Loxo Oncology Inc Business Overview
11.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Introduction
11.9.4 Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.9.5 Loxo Oncology Inc Recent Development
11.10 Merck & Co Inc
11.10.1 Merck & Co Inc Company Details
11.10.2 Merck & Co Inc Business Overview
11.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Introduction
11.10.4 Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.10.5 Merck & Co Inc Recent Development
11.11 Nerviano Medical Sciences Srl
11.11.1 Nerviano Medical Sciences Srl Company Details
11.11.2 Nerviano Medical Sciences Srl Business Overview
11.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Introduction
11.11.4 Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.11.5 Nerviano Medical Sciences Srl Recent Development
11.12 Plexxikon Inc
11.12.1 Plexxikon Inc Company Details
11.12.2 Plexxikon Inc Business Overview
11.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Introduction
11.12.4 Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.12.5 Plexxikon Inc Recent Development
11.13 Proximagen Ltd
11.13.1 Proximagen Ltd Company Details
11.13.2 Proximagen Ltd Business Overview
11.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Introduction
11.13.4 Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.13.5 Proximagen Ltd Recent Development
11.14 Rottapharm Biotech Srl
11.14.1 Rottapharm Biotech Srl Company Details
11.14.2 Rottapharm Biotech Srl Business Overview
11.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Introduction
11.14.4 Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.14.5 Rottapharm Biotech Srl Recent Development
11.15 Sienna Biopharmaceuticals Inc
11.15.1 Sienna Biopharmaceuticals Inc Company Details
11.15.2 Sienna Biopharmaceuticals Inc Business Overview
11.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Introduction
11.15.4 Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.15.5 Sienna Biopharmaceuticals Inc Recent Development
11.16 Tiziana Life Sciences Plc
11.16.1 Tiziana Life Sciences Plc Company Details
11.16.2 Tiziana Life Sciences Plc Business Overview
11.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Introduction
11.16.4 Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
11.16.5 Tiziana Life Sciences Plc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global High Affinity Nerve Growth Factor Receptor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of ASP-7962
Table 3. Key Players of AZD-7451
Table 4. Key Players of BNN-27
Table 5. Key Players of Cenegermin
Table 6. Key Players of CRB-0089
Table 7. Key Players of Others
Table 8. Global High Affinity Nerve Growth Factor Receptor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global High Affinity Nerve Growth Factor Receptor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global High Affinity Nerve Growth Factor Receptor Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global High Affinity Nerve Growth Factor Receptor Market Share by Regions (2016-2021)
Table 12. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global High Affinity Nerve Growth Factor Receptor Market Share by Regions (2022-2027)
Table 14. High Affinity Nerve Growth Factor Receptor Market Trends
Table 15. High Affinity Nerve Growth Factor Receptor Market Drivers
Table 16. High Affinity Nerve Growth Factor Receptor Market Challenges
Table 17. High Affinity Nerve Growth Factor Receptor Market Restraints
Table 18. Global High Affinity Nerve Growth Factor Receptor Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global High Affinity Nerve Growth Factor Receptor Market Share by Players (2016-2021)
Table 20. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2020)
Table 21. Ranking of Global Top High Affinity Nerve Growth Factor Receptor Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
Table 25. Date of Enter into High Affinity Nerve Growth Factor Receptor Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 28. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2016-2021)
Table 29. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2016-2021)
Table 33. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 36. North America High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 38. North America High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2022-2027) & (US$ Million)
Table 65. Array BioPharma Inc Company Details
Table 66. Array BioPharma Inc Business Overview
Table 67. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product
Table 68. Array BioPharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 69. Array BioPharma Inc Recent Development
Table 70. Astellas Pharma Inc Company Details
Table 71. Astellas Pharma Inc Business Overview
Table 72. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product
Table 73. Astellas Pharma Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 74. Astellas Pharma Inc Recent Development
Table 75. AstraZeneca Plc Company Details
Table 76. AstraZeneca Plc Business Overview
Table 77. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product
Table 78. AstraZeneca Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 79. AstraZeneca Plc Recent Development
Table 80. Daiichi Sankyo Co Ltd Company Details
Table 81. Daiichi Sankyo Co Ltd Business Overview
Table 82. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product
Table 83. Daiichi Sankyo Co Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 84. Daiichi Sankyo Co Ltd Recent Development
Table 85. Dompe Farmaceutici SpA Company Details
Table 86. Dompe Farmaceutici SpA Business Overview
Table 87. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product
Table 88. Dompe Farmaceutici SpA Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 89. Dompe Farmaceutici SpA Recent Development
Table 90. Genzyme Corp Company Details
Table 91. Genzyme Corp Business Overview
Table 92. Genzyme Corp High Affinity Nerve Growth Factor Receptor Product
Table 93. Genzyme Corp Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 94. Genzyme Corp Recent Development
Table 95. Handok Inc Company Details
Table 96. Handok Inc Business Overview
Table 97. Handok Inc High Affinity Nerve Growth Factor Receptor Product
Table 98. Handok Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 99. Handok Inc Recent Development
Table 100. Ignyta Inc Company Details
Table 101. Ignyta Inc Business Overview
Table 102. Ignyta Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 103. Ignyta Inc Recent Development
Table 104. Loxo Oncology Inc Company Details
Table 105. Loxo Oncology Inc Business Overview
Table 106. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product
Table 107. Loxo Oncology Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 108. Loxo Oncology Inc Recent Development
Table 109. Merck & Co Inc Company Details
Table 110. Merck & Co Inc Business Overview
Table 111. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product
Table 112. Merck & Co Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 113. Merck & Co Inc Recent Development
Table 114. Nerviano Medical Sciences Srl Company Details
Table 115. Nerviano Medical Sciences Srl Business Overview
Table 116. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Product
Table 117. Nerviano Medical Sciences Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 118. Nerviano Medical Sciences Srl Recent Development
Table 119. Plexxikon Inc Company Details
Table 120. Plexxikon Inc Business Overview
Table 121. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Product
Table 122. Plexxikon Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 123. Plexxikon Inc Recent Development
Table 124. Proximagen Ltd Company Details
Table 125. Proximagen Ltd Business Overview
Table 126. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Product
Table 127. Proximagen Ltd Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 128. Proximagen Ltd Recent Development
Table 129. Rottapharm Biotech Srl Company Details
Table 130. Rottapharm Biotech Srl Business Overview
Table 131. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Product
Table 132. Rottapharm Biotech Srl Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 133. Rottapharm Biotech Srl Recent Development
Table 134. Sienna Biopharmaceuticals Inc Company Details
Table 135. Sienna Biopharmaceuticals Inc Business Overview
Table 136. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Product
Table 137. Sienna Biopharmaceuticals Inc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 138. Sienna Biopharmaceuticals Inc Recent Development
Table 139. Tiziana Life Sciences Plc Company Details
Table 140. Tiziana Life Sciences Plc Business Overview
Table 141. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Product
Table 142. Tiziana Life Sciences Plc Revenue in High Affinity Nerve Growth Factor Receptor Business (2016-2021) & (US$ Million)
Table 143. Tiziana Life Sciences Plc Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global High Affinity Nerve Growth Factor Receptor Market Share by Type: 2020 VS 2027
Figure 2. ASP-7962 Features
Figure 3. AZD-7451 Features
Figure 4. BNN-27 Features
Figure 5. Cenegermin Features
Figure 6. CRB-0089 Features
Figure 7. Others Features
Figure 8. Global High Affinity Nerve Growth Factor Receptor Market Share by Application: 2020 VS 2027
Figure 9. Bile Duct Cancer Case Studies
Figure 10. Papillary Thyroid Cancer Case Studies
Figure 11. Low Back Pain Case Studies
Figure 12. Lung Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. High Affinity Nerve Growth Factor Receptor Report Years Considered
Figure 15. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global High Affinity Nerve Growth Factor Receptor Market Share by Regions: 2020 VS 2027
Figure 18. Global High Affinity Nerve Growth Factor Receptor Market Share by Regions (2022-2027)
Figure 19. Global High Affinity Nerve Growth Factor Receptor Market Share by Players in 2020
Figure 20. Global Top High Affinity Nerve Growth Factor Receptor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2020
Figure 21. The Top 10 and 5 Players Market Share by High Affinity Nerve Growth Factor Receptor Revenue in 2020
Figure 22. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2016-2021)
Figure 23. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2022-2027)
Figure 24. North America High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America High Affinity Nerve Growth Factor Receptor Market Share by Type (2016-2027)
Figure 26. North America High Affinity Nerve Growth Factor Receptor Market Share by Application (2016-2027)
Figure 27. North America High Affinity Nerve Growth Factor Receptor Market Share by Country (2016-2027)
Figure 28. United States High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe High Affinity Nerve Growth Factor Receptor Market Share by Type (2016-2027)
Figure 32. Europe High Affinity Nerve Growth Factor Receptor Market Share by Application (2016-2027)
Figure 33. Europe High Affinity Nerve Growth Factor Receptor Market Share by Country (2016-2027)
Figure 34. Germany High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Type (2016-2027)
Figure 42. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Application (2016-2027)
Figure 43. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Region (2016-2027)
Figure 44. China High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Type (2016-2027)
Figure 52. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Application (2016-2027)
Figure 53. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country (2016-2027)
Figure 54. Mexico High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Type (2016-2027)
Figure 58. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Application (2016-2027)
Figure 59. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country (2016-2027)
Figure 60. Turkey High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE High Affinity Nerve Growth Factor Receptor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Array BioPharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 64. Astellas Pharma Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 65. AstraZeneca Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 66. Daiichi Sankyo Co Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 67. Dompe Farmaceutici SpA Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 68. Genzyme Corp Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 69. Handok Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 70. Ignyta Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 71. Loxo Oncology Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 72. Merck & Co Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 73. Nerviano Medical Sciences Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 74. Plexxikon Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 75. Proximagen Ltd Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 76. Rottapharm Biotech Srl Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 77. Sienna Biopharmaceuticals Inc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 78. Tiziana Life Sciences Plc Revenue Growth Rate in High Affinity Nerve Growth Factor Receptor Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

---